Zapata-Cobo, P., Salvador-Martin, S., Velasco, M., Palomino, L., Clemente, S., Segarra, O., . . . Lopez-Fernandez, L. (2023). Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Citación estilo ChicagoZapata-Cobo, P., et al. Polymorphisms Indicating Risk of Inflammatory Bowel Disease or Antigenicity to Anti-TNF Drugs As Biomarkers of Response in Children. 2023.
Cita MLAZapata-Cobo, P., et al. Polymorphisms Indicating Risk of Inflammatory Bowel Disease or Antigenicity to Anti-TNF Drugs As Biomarkers of Response in Children. 2023.
Precaución: Estas citas no son 100% exactas.